Abl Bio-Technologies Profile
Key Indicators
- Authorised Capital ₹ 20.00 Cr
as on 05-07-2024
- Paid Up Capital ₹ 8.20 Cr
as on 05-07-2024
- Company Age 32 Year, 9 Months
- Last Filing with ROC 31 Mar 2012
- Open Charges ₹ 8.44 Cr
as on 05-07-2024
- Satisfied Charges ₹ 7.50 Cr
as on 05-07-2024
About Abl Bio-Technologies
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2012. It's a company limited by shares with an authorized capital of Rs 20.00 Cr and a paid-up capital of Rs 8.20 Cr.
The company currently has active open charges totaling ₹8.44 Cr. The company has closed loans amounting to ₹7.50 Cr, as per Ministry of Corporate Affairs (MCA) records.
Kollenmareth Isaac, Sankaran Madhavan, and Subramanian Gopalakrishnan serve as directors at the Company.
- CIN/LLPIN
L52599TN1992PLC022340
- Company No.
022340
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
16 Mar 1992
- Date of AGM
28 Sep 2012
- Date of Balance Sheet
31 Mar 2012
- Listing Status
Listed
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Abl Bio-Technologies?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kollenmareth Isaac  | Managing Director | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sankaran Madhavan | Director | 13-Dec-2008 | Current |
| Subramanian Gopalakrishnan | Director | 30-Oct-2003 | Current |
Financial Performance and Corporate Structure Insights of Abl Bio-Technologies.
Enhance accessibility to Abl Bio-Technologies's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Abl Bio-Technologies?
Unlock access to Abl Bio-Technologies's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
International Asset Reconstruction Company Private Limited Creation Date: 10 Jan 2008 | ₹3.00 M | Open |
International Asset Reconstruction Company Private Limited Creation Date: 01 Dec 2007 | ₹4.60 Cr | Open |
Sbi Facotrs & Commercial Services Private Ltd Creation Date: 21 Dec 2005 | ₹9.50 M | Open |
How Many Employees Work at Abl Bio-Technologies?
Unlock and access historical data on people associated with Abl Bio-Technologies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Abl Bio-Technologies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Abl Bio-Technologies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
